Alpha Teknova Inc   (TKNO)
Other Ticker:  
Price: $2.1700 $0.27 14.211%
Day's High: $2.17 Week Perf: 69.53 %
Day's Low: $ 1.90 30 Day Perf: 35.63 %
Volume (M): 421 52 Wk High: $ 4.27
Volume (M$): $ 913 52 Wk Avg: $2.42
Open: $1.95 52 Wk Low: $1.16

 Market Capitalization (Millions $) 65
 Shares Outstanding (Millions) 30
 Employees -
 Revenues (TTM) (Millions $) 36
 Net Income (TTM) (Millions $) -39
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) 12

Alpha Teknova Inc
Alpha Teknova Inc is a technology company specializing in product development and innovation. The company focuses on providing cutting-edge solutions for various industries including biotechnology, pharmaceuticals, and research. Alpha Teknova Inc aims to deliver high-quality products, such as reagents, enzymes, and assays, that meet the needs of its clients and contribute to advancements in science and medicine. The company is known for its commitment to innovation, quality, and customer satisfaction.

   Company Address: 2451 Bert Dr. Hollister 95023 CA
   Company Phone Number: 637-1100   Stock Exchange / Ticker: NASDAQ TKNO


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report


Teknova Raises $38.3 Million in Private Placements and Offering, Strengthens Position in Medical Research Sector

Published Fri, Jul 12 2024 8:26 PM UTC

Additionally, Teknova has also completed a registered direct offering, where it issued and sold up to 1,086,485 shares of common stock at $1.85 per share. In a concurrent private placement, the company sold an additional 11,299,993 shares at the same purchase price. These offerings were priced based on the consolidated closing bid price under Nasdaq rules.
In total,...

Management Announcement

Teknova Announces $15.4 Million Private Placement as Shares Plummet

Published Fri, Jul 12 2024 5:00 AM UTC

HOLLISTER, Calif., July 11, 2024 - Alpha Teknova, Inc. (Teknova), a renowned producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, has recently disclosed a significant development in its financial strategy. The company announced that it has entered into a definitive agreement for...

Product Service News

Teknova Unveils Game-Changing Tools to Advance Novel Therapy Development

Published Tue, May 7 2024 2:01 PM UTC

Teknova Launches Proprietary Build-Tek Solutions Custom Configurator and Latest AAV-Tek Product to Further Accelerate Novel Therapy DevelopmentInnovative biotechnology company Teknova has announced the launch of its groundbreaking Build-Tek Solutions Custom Configurator and the latest product in its AAV-Tek range. These tools are set to revolutionize the field of novel thera...

Alpha Teknova Inc

Alpha Teknova Inc's Profits Plunge in Financial Q3 of 2023, Reflecting Challenging Times

In a recent announcement, Alpha Teknova, Inc. (Teknova) revealed its plans to raise up to $22.9 million through a registered direct offering and private placement. The funds raised will be used to accelerate research and development of life-saving therapies, vaccines, and molecular diagnostics. This strategic move aims to strengthen Teknova's position in the market and support the advancement of life-saving treatments.
Under the definitive agreements, Teknova will issue and sell up to 1,086,485 shares of its common stock in a registered direct offering at a purchase price of $1.85 per share. Additionally, the company has entered into an agreement to sell an additional 11,299,993 shares of common stock at the same purchase price in a private placement. The pricing of the shares in both offerings adheres to Nasdaq rules, based on the consolidated closing bid price.


Teknova Raises $22.9 Million to Advance Life-Saving Therapies and Research

Published Mon, Sep 18 2023 12:00 PM UTC

Teknova Announces $22.9 Million Offering to Accelerate Research and Development of Life-saving Therapies
HOLLISTER, Calif., Sept. 18, 2023 - Alpha Teknova, Inc. (Teknova) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, revealed today its plans to raise up...


Alpha Teknova Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com